tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RXRX Stock Latest News

Recursion Pharmaceuticals call volume above normal and directionally bullish
The FlyRecursion Pharmaceuticals call volume above normal and directionally bullish
3d ago
RXRX
Unusually active option classes on open October 20th
PremiumThe Fly
Unusually active option classes on open October 20th
3d ago
AUR
CAN
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
8d ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
9d ago
RXRX
Recursion Pharmaceuticals rises 17.9%
PremiumThe Fly
Recursion Pharmaceuticals rises 17.9%
15d ago
RXRX
Unusually active option classes on open September 25th
PremiumThe FlyUnusually active option classes on open September 25th
28d ago
BB
ACN
Strategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals
Premium
Ratings
Strategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals
1M ago
RXRX
Recursion Pharmaceuticals management to meet with Needham
Premium
The Fly
Recursion Pharmaceuticals management to meet with Needham
1M ago
RXRX
Buy Recommendation for Recursion Pharmaceuticals: Strong Position in AI-Driven Drug Discovery with Strategic Acquisitions and Financial Stability
PremiumRatings
Buy Recommendation for Recursion Pharmaceuticals: Strong Position in AI-Driven Drug Discovery with Strategic Acquisitions and Financial Stability
2M ago
RXRX
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
PremiumThe Fly
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
2M ago
AI
GS
Rallybio receives $12.5M equity milestone payment from Recursion Pharmaceuticals
PremiumThe Fly
Rallybio receives $12.5M equity milestone payment from Recursion Pharmaceuticals
2M ago
RLYB
RXRX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
ING
AMPY
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
ETH
KGC
Nvidia discloses increased CoreWeave stake of $3.96B
Premium
The Fly
Nvidia discloses increased CoreWeave stake of $3.96B
2M ago
ARM
APLD
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
ING
CHYM
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
RXRX
Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
3M ago
RXRX
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
PremiumRatings
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
3M ago
RXRX
Recursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
PremiumRatings
Recursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
3M ago
RXRX
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsRecursion Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
8K
RXRX
Recursion Pharmaceuticals reports Q2 EPS (41c), consensus (35c)
Premium
The Fly
Recursion Pharmaceuticals reports Q2 EPS (41c), consensus (35c)
3M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
3M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >